Form 4 Tracker
Daniel J. Lippis

CVP, TAVR · 14 filings · Latest: Oct 8, 2026

Edwards Lifesciences Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
EW
Daniel J. LippisCVP, TAVRApr 6, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Daniel J. LippisCVP, TAVRMar 11, 2026
Sale
$85.381,019$87.0K33,933.91
EW
Daniel J. LippisCVP, TAVRMar 11, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Lippis Daniel J.—Mar 11, 2026
Proposed Sale
$85.383,057$261.0K—
EW
Lippis Daniel J.—Nov 10, 2025
Proposed Sale
$82.553,058$252.4K—
EW
Lippis Daniel J.—Jul 28, 2025
Proposed Sale
$79.464,114$326.9K—
EW
Lippis Daniel J.—May 9, 2025
Proposed Sale
$74.42330$24.6K—
EW
Lippis Daniel J.—Apr 8, 2025
Proposed Sale
$70.61300$21.2K—
EW
Lippis Daniel J.—Mar 10, 2025
Proposed Sale
$69.48400$27.8K—
EW
Lippis Daniel J.—Feb 13, 2025
Proposed Sale
$76.34500$38.2K—
EW
Lippis Daniel J.—Jan 16, 2025
Proposed Sale
$68.76500$34.4K—
EW
Lippis Daniel J.—Dec 16, 2024
Proposed Sale
$74.082,500$185.2K—

← Previous

Page 2 of 2